Αρχική World News Findings from a Population-Based Study on Cancers Associated with Alcohol Consumption

Findings from a Population-Based Study on Cancers Associated with Alcohol Consumption

Updated worldwide estimates of cancers associated with alcohol consumption stratified by gender, tumour localisation and country indicate causal relation of alcohol with a substantial number of cancer cases that could potentially be avoided. Among all new cancers in 2020, 4.1% were related to alcohol consumption. The numbers were higher among males and also in case of risky and heavy alcohol consumption. Among tumour types, those most frequently related to alcohol consumption were oesophageal, liver and breast cancers. Population attributable fractions were highest in eastern Asia, and central and eastern Europe. Harriet Rumgay, BSc of the International Agency for Research on Cancer in Lyon, France and colleagues published their findings online on 13 July 2021 in The Lancet Oncology.

Alcohol consumption is causally linked to oral, pharyngeal, laryngeal, oesophageal, colon, rectal, liver, and female breast cancers. Based on the GLOBOCAN 2020 database, those cancers were reported in 6.3 million cases and caused 3.3 million deaths worldwide in 2020.

The study team wrote that patterns of alcohol consumption change over time across regions. It has decreased in many European countries, but it is on the rise in some Asian countries and in sub-Saharan Africa.

The authors updated previous worldwide estimates by using the GLOBOCAN cancer incidence estimates for 2020, recent relative risk estimates from the literature and information on patterns of alcohol consumption across the world. They quantified the contribution of moderate drinking defined as consumption of less than 20 g of alcohol per day, risky drinking as consumption of 20 to 60 g of alcohol per day and heavy drinking as consumption of more than 60 g of alcohol per day.  

Estimated population attributable fraction in this report was lower than the previous worldwide estimates. The authors commented that this difference could be due to decreases in alcohol consumption in several world regions, e.g. in southern Europe and central and eastern Europe.

Three quarters of cancers associated with alcohol consumption were recorded in males, in particular 76.7% in males versus 23.3% in females. The worldwide age-standardised incidence rate was 8.4 cancer cases associated with alcohol consumption per 100 000 people; 13.4 cancer cases per 100 000 males and 3.7 cancer cases per 100 000 females. There were also considerable differences in cancer sites in terms of sex.

Population attributable fractions in this report were lowest in northern Africa (0.3%) and western Asia (0.7%), and highest in eastern Asia (5.7%) and central and eastern Europe (5.6%). 

Risky and heavy drinking contributed most, but it is worthy to say that moderate drinking contributed one in seven cancer cases associated with alcohol consumption and caused more than 100 000 cancer cases worldwide.

The study team advocates in their report for a range of public policy-oriented interventions to increase awareness of the cancer risk and decrease alcohol consumption. They predict increase in alcohol consumption until at least 2030 in several world regions. Therefore, the policy actions could reduce such avoidable risk of cancer.


Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. The Lancet Oncology; Published online 13 July 2021. DOI: https://doi.org/10.1016/S1470-2045(21)00279-5



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...